v3 Template
B

BiomX Inc.

Biotechnology / Healthcare NESS ZIONA, Israel ~280 employees
Founded
--
Employees (Est.)
~280
14 leaders known
Total Funding
$30.0M
Funding Rounds
4
Last Funding
2025-12-29

About BiomX Inc.

BiomX is a company focused on advancing medicine through customized phage therapies to eradicate harmful bacteria in chronic diseases such as cystic fibrosis and diabetic foot osteomyelitis. They develop natural and engineered phage cocktails and personalized treatments targeting specific bacterial strains.

Products & Services

BX004 for Cystic Fibrosis:A phage therapy in Phase II clinical trials targeting harmful bacteria in cystic fibrosis patients.
BX005 for Atopic Dermatitis:A product candidate for atopic dermatitis, with a licensing agreement in Japan.
XMarker Biomarker Discovery Platform:A microbiome-based platform for identifying biomarkers associated with diseases like inflammatory bowel disease (IBD), used in collaborations with pharmaceutical companies.

Specialties

Phage Therapy Bacteriophage Technology Biomarker Discovery Chronic Disease Treatment Microbiome-based Therapeutics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement 		A: 3000000
MR: -
FA: 3.0 million
FAN: 3000000 		D: 2025-12-29
FD: 2025-12-29 		-
2 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement 		A: 12000000
MR: -
FA: $12 million
FAN: 12000000 		D: 2025-02-26
FD: 2025-02-26 		3 investors
3 RT: Private Placement
T: -
FT: Private Placement 		A: 7500000
MR: -
FA: 7.5 million
FAN: 7500000 		D: 2023-05-05
FD: 2023-05-05 		2 investors
4 RT: Private Placement
T: -
FT: Private Placement 		A: 7500000
MR: -
FA: 7.5 million
FAN: 7500000 		D: 2023-02-22
FD: 2023-02-22 		2 investors
Private Placement Latest
2025-12-29
$3.0M
Registered Direct Offering and Private Placement 2025-02-26
$12.0M
Private Placement 2023-05-05
$7.5M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Jonathan Solomon

CEO & Board Member

LinkedIn (Pro only)
M

Merav Bassan

CDO

LinkedIn (Pro only)
M

Marina Wolfson

CFO

LinkedIn (Pro only)
I

Inbal Benjamini-Elran

CHRO

R

Russell Greig

Chairman of the Board of Directors

J

Jonathan Leff

Director

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

BiomX Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
biomx.com
Industries
Biotechnology / Healthcare
Company Size
~280 employees (est.)
Locations
NESS ZIONA, Israel

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro